As of Aug 17
| -2.60 / -2.09%|
The 17 analysts offering 12-month price forecasts for Incyte Corp have a median target of 145.00, with a high estimate of 172.00 and a low estimate of 113.00. The median estimate represents a +19.11% increase from the last price of 121.74.
The current consensus among 21 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.